Arcturus Therapeutics Holdings Inc. (ARCT) Financial Statements (2024 and earlier)

Company Profile

Business Address 10628 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments292,005391,883370,492462,89571,353
Cash and cash equivalents292,005391,883370,492462,89571,353
Restricted cash and investments55,000    
Receivables32,0642,7643,3672,1252,179
Other undisclosed current assets7,5218,6865,1022,769758
Total current assets:386,590403,333378,961467,78974,290
Noncurrent Assets
Operating lease, right-of-use asset28,50032,5455,6185,1825,134
Property, plant and equipment12,42712,4155,6433,3782,349
Long-term investments and receivables   515 263
Long-term investments   515 263
Restricted cash and investments1,8852,0942,077107107
Total noncurrent assets:42,81247,05413,8538,6677,853
TOTAL ASSETS:429,402450,387392,814476,45682,143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37,16037,68133,58131,41312,927
Accounts payable5,2797,44910,05810,7745,793
Accrued liabilities31,88130,23223,52320,6397,134
Deferred revenue44,82928,64843,48218,1088,397
Debt  60,65522,474  
Total current liabilities:81,989126,98499,53749,52121,324
Noncurrent Liabilities
Long-term debt and lease obligation   45,13517,87019,845
Long-term debt, excluding current maturities   40,63313,84514,995
Liabilities, other than long-term debt68,90053,09119,93112,51215,182
Deferred revenue42,49620,07119,93112,51215,182
Other liabilities 4972,804   
Operating lease, liability25,90730,2164,5024,0254,850
Total noncurrent liabilities:68,90053,09165,06630,38235,027
Total liabilities:150,889180,075164,60379,90356,351
Equity
Equity, attributable to parent278,513270,312228,211396,55325,792
Common stock2727262615
Additional paid in capital646,352608,426575,675540,34397,445
Accumulated deficit(367,866)(338,141)(347,490)(143,816)(71,668)
Total equity:278,513270,312228,211396,55325,792
TOTAL LIABILITIES AND EQUITY:429,402450,387392,814476,45682,143

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues166,799205,99912,3599,53920,789
Gross profit:166,799205,99912,3599,53920,789
Operating expenses(245,004)(193,822)(215,211)(81,063)(46,302)
Operating income (loss):(78,205)12,177(202,852)(71,524)(25,513)
Nonoperating income (expense)16,362(1,018)(1,337)(361)(446)
Gain (loss), foreign currency transaction, before tax(229)(598)584  
Other nonoperating income (expense)16,591(420)(1,921)(361)(446)
Interest and debt expense 33,953(900)(2,700)(900)(900)
Income (loss) from continuing operations before equity method investments, income taxes:(27,890)10,259(206,889)(72,785)(26,859)
Income (loss) from equity method investments  (515)515(263)(32)
Other undisclosed income from continuing operations before income taxes  900   
Income (loss) from continuing operations before income taxes:(27,890)10,644(206,374)(73,048)(26,891)
Income tax expense(1,835)(1,295)   
Income (loss) from continuing operations:(29,725)9,349(206,374)(73,048)(26,891)
Loss before gain (loss) on sale of properties:(206,374)(73,048)(26,891)
Net income (loss):(29,725)9,349(206,374)(73,048)(26,891)
Other undisclosed net income attributable to parent   2,700900900
Net income (loss) available to common stockholders, diluted:(29,725)9,349(203,674)(72,148)(25,991)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(29,725)9,349(206,374)(73,048)(26,891)
Comprehensive income (loss):(29,725)9,349(206,374)(73,048)(26,891)
Other undisclosed comprehensive income, net of tax, attributable to parent   2,700900900
Comprehensive income (loss), net of tax, attributable to parent:(29,725)9,349(203,674)(72,148)(25,991)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: